Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer

BACKGROUND: MammaPrint (MMP) helps clinicians identify the ideal time for adjuvant treatment for patients with early HR+/HER2− breast cancer. We aimed to validate a nomogram designed to predict probability of low risk of MMP results and to evaluate the difference in survival outcome between two grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Young Sol, Kim, Hwa Jung, Kim, Jisun, Chung, Il Yong, Ko, Beom Seok, Kim, Hee Jeong, Lee, Jong Won, Son, Byung Ho, Ahn, Sei-Hyun, Lee, Sae Byul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789221/
https://www.ncbi.nlm.nih.gov/pubmed/36564593
http://dx.doi.org/10.1007/s12672-022-00604-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789221/
https://www.ncbi.nlm.nih.gov/pubmed/36564593
http://dx.doi.org/10.1007/s12672-022-00604-z

Ejemplares similares